Alterations of ocular nitric oxide synthase in human glaucoma
- PMID: 7543463
Alterations of ocular nitric oxide synthase in human glaucoma
Erratum in
- Invest Ophthalmol Vis Sci 1995 Nov;36(12):2333
Abstract
Purpose: The authors recently reported that sites of outflow resistance and regulation in the human eye are highly enriched in the endothelial isoform of nitric oxide (NO) synthase (ecNOS). In vasculature, ecNOS activation is associated with altered vascular resistance and, in the stomach, defects in NO are associated with pathologic gastric hypertension. Because human glaucoma sometimes is associated with an increase in intraocular pressure and resistance changes in the aqueous outflow pathway (OP), the authors have investigated the possibility that alterations in NO or defects in NO-synthesizing tissues might exist in glaucomatous eyes.
Methods: Occurrence, distribution, and extent of sites of ocular NO production in the anterior segments of 16 normal eyes (10 patients) and 17 eyes (12 patients) with a history of primary open-angle glaucoma (POAG) were determined using the NO-indicator marker, NADPH-diaphorase (NADPH-d), which is known to colocalize with ecNOS immunoreactivity. Analysis of NADPH-d reactivity in tissues was combined with examination of overall cell distribution and use of neuron-specific markers.
Results: The ciliary muscle (CM) and OP of glaucomatous eyes showed marked differences in the amount and distribution of NADPH-d and alterations in gross structure. NADPH-d reactivity was decreased in trabecular meshwork (TM) and Schlemm's canal, and there was a marked reduction of anterior longitudinal CM fibers that insert near (and may normally regulate resistance in) the TM.
Conclusion: Abnormalities in NO or NO-containing cells occur in POAG. These abnormalities may be causally related to glaucoma or may be a manifestation of the disease or its treatment. In either case, such alterations, together with recent pharmacologic studies showing that NO-mimicking nitrovasodilators alter IOP, indicate that NO has relevance to the course, treatment, or both, or some forms of this disease.
Similar articles
-
Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye.Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1765-73. Invest Ophthalmol Vis Sci. 1995. PMID: 7543462
-
Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine.Fundam Clin Pharmacol. 2012 Feb;26(1):86-117. doi: 10.1111/j.1472-8206.2011.00969.x. Epub 2011 Aug 24. Fundam Clin Pharmacol. 2012. PMID: 21883446 Review.
-
Segmental variability of the trabecular meshwork in normal and glaucomatous eyes.Invest Ophthalmol Vis Sci. 1994 Oct;35(11):3841-51. Invest Ophthalmol Vis Sci. 1994. PMID: 7928181
-
Retroperfusion studies of the aqueous outflow system. Part 2: Studies in human eyes.Invest Ophthalmol Vis Sci. 1995 Nov;36(12):2466-75. Invest Ophthalmol Vis Sci. 1995. PMID: 7591636
-
Structural changes of the trabecular meshwork in different kinds of glaucoma.Exp Eye Res. 2009 Apr;88(4):769-75. doi: 10.1016/j.exer.2008.11.025. Epub 2008 Dec 6. Exp Eye Res. 2009. PMID: 19114037 Review.
Cited by
-
Effect of nitric oxide on anterior segment physiology in monkeys.Invest Ophthalmol Vis Sci. 2013 Jul 30;54(7):5103-10. doi: 10.1167/iovs.12-11491. Invest Ophthalmol Vis Sci. 2013. PMID: 23800771 Free PMC article.
-
Vascular Endothelial Growth Factor -460 C/T BstUI Gene Polymorphism is associated with Primary Open Angle Glaucoma.Biomedicine (Taipei). 2014;4(1):4. doi: 10.7603/s40681-014-0004-3. Epub 2014 Aug 6. Biomedicine (Taipei). 2014. PMID: 25520917 Free PMC article.
-
Targeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.Adv Ther. 2017 May;34(5):1049-1069. doi: 10.1007/s12325-017-0513-z. Epub 2017 Mar 27. Adv Ther. 2017. PMID: 28349508 Free PMC article. Review.
-
Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2.Cells. 2022 Nov 23;11(23):3741. doi: 10.3390/cells11233741. Cells. 2022. PMID: 36497005 Free PMC article.
-
Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open-angle glaucoma and ocular hypertension.Clin Exp Optom. 2019 Nov;102(6):541-550. doi: 10.1111/cxo.12853. Epub 2019 Jan 7. Clin Exp Optom. 2019. PMID: 30614563 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous